Success for SNG 001 (Synairgen) in early Asthma trial - 06-Sep-2012

In a mid-stage study of 134 adults who caught a cold, SNG001 from Synairgen, was effective in the most difficult-to-treat patients, preventing asthma symptoms from getting worse during the first week of infection and treatment. There was also a 65 percent reduction in the number of patients who experienced asthma attacks during the treatment period compared with a group on placebo. SNG001 is a beta interferon treatment that works by targeting virus infections, which trigger 80 percent of asthma attacks.

Related News

Phase II study of Favorite (Activaero) shows superiority over conventional Asthma treatment

Analysis of two Phase III studies shows Spiriva (Boehringer) provides benefits for Asthma patients

FDA approves Aerospan (Acton Pharma) for Asthma

Success for SNG 001 (Synairgen) in early Asthma trial

Positive data from Phase III trial of Spiriva (Boehringer) in Asthma patients

Bosatria (GSK) study in severe Eosinophilic Asthma

FDA approves generic Singulair for Asthma

Fluticasone/vilanterol combination (GSK) is filed in US for COPD and in the EU for Asthma and COPD

Related Respiratory Information

View all

Respiratory Clinical Guidelines

Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control

NICE

Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin

NICE
View all

Respiratory Clinical Trials

Moderate to Severe Bronchiolitis: Standard Therapy Versus Therapy With NaCl 3% Inhalations

Clinicaltrials.gov 14 March 2013

A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia

Clinical Trials Register.eu 08 March 2013
View all

Respiratory Medical Journal Abstracts

Safety and efficacy of paclitaxel liposome for elderly patients with advanced non-small cell lung cancer: A multi-center prospective study

Thoracic Cancer 04 February 2013

Angiopoietin 2 levels in serum and bronchial lavage fluids and their relationship with cancer stages in lung cancer patients

Thoracic Cancer 04 February 2013
View all

Respiratory Medical Apps

Blausen Respiratory Atlas

£2.99

Asthma Info

Free

Related Respiratory Drugs

Back to top
View all

Latest News

Takeda acquires vaccine maker Inviragen

10 May 2015

Takeda Pharmaceutical Company Limited and Inviragen, Inc. jointly announced that Takeda, its wholly owned subsidiary Takeda America...

Read full article

SAR 302503 (Sanofi) successs in JAKARTA study of Myelofibrosis

18 May 2013

Sanofi has announced that the pivotal study, JAKARTA, examining the selective JAK2 inhibitor SAR 302503 for Myelofibrosis versus placebo...

Read full article

Phase III study of NEPA (Helsinn and Eisai) meets endpoint in patients with Nausea

18 May 2013

Top-line results from a pivotal Phase III clinical study investigating NEPA (netupitant and palonosetron), from Helsinn and Eisai, for...

Read full article